Real Heart (HEART) - Total Liabilities

Latest as of June 2025: Skr13.59 Million SEK ≈ $1.46 Million USD

Based on the latest financial reports, Real Heart (HEART) has total liabilities worth Skr13.59 Million SEK (≈ $1.46 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See Real Heart (HEART) working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Real Heart - Total Liabilities Trend (2010–2024)

This chart illustrates how Real Heart's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see how large is Real Heart's balance sheet.

Real Heart Competitors by Total Liabilities

The table below lists competitors of Real Heart ranked by their total liabilities.

Company Country Total Liabilities
Global Oriental Bhd
KLSE:1147
Malaysia RM497.97 Million
Taitron Components Incorporated
NASDAQ:TAIT
USA $2.02 Million
Scottish American Investment Co
LSE:SAIN
UK GBX100.90 Million
Titan Logix Corp.
V:TLA
Canada CA$1.01 Million
Opthea Ltd
AU:OPT
Australia AU$256.70 Million
Megalestari Epack Sentosaraya Pt
JK:EPAC
Indonesia Rp184.47 Billion
Mint Incorporation Limited Class A Ordinary Shares
NASDAQ:MIMI
USA $1.78 Million
BIGG Digital Assets Inc
F:7111
Germany €129.44 Million

Liability Composition Analysis (2010–2024)

This chart breaks down Real Heart's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See HEART equity financing ratio to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 2.96 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.18 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.15 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Real Heart's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Real Heart (2010–2024)

The table below shows the annual total liabilities of Real Heart from 2010 to 2024.

Year Total Liabilities Change
2024-12-31 Skr15.94 Million
≈ $1.72 Million
-22.62%
2023-12-31 Skr20.60 Million
≈ $2.22 Million
-7.08%
2022-12-31 Skr22.17 Million
≈ $2.39 Million
+239.78%
2021-12-31 Skr6.53 Million
≈ $702.20K
+2.75%
2020-12-31 Skr6.35 Million
≈ $683.39K
-16.57%
2019-12-31 Skr7.61 Million
≈ $819.12K
-6.31%
2018-12-31 Skr8.12 Million
≈ $874.25K
+26.15%
2017-12-31 Skr6.44 Million
≈ $693.01K
+60.72%
2016-12-31 Skr4.01 Million
≈ $431.18K
+534.12%
2015-12-31 Skr631.85K
≈ $68.00K
-26.28%
2014-12-31 Skr857.12K
≈ $92.24K
+1.78%
2013-12-31 Skr842.11K
≈ $90.62K
+91.93%
2012-12-31 Skr438.75K
≈ $47.22K
+613.58%
2011-12-31 Skr61.49K
≈ $6.62K
-15.36%
2010-12-31 Skr72.65K
≈ $7.82K
--

About Real Heart

ST:HEART Sweden Medical Devices
Market Cap
$9.68 Million
Skr89.98 Million SEK
Market Cap Rank
#27240 Global
#591 in Sweden
Share Price
Skr18.00
Change (1 day)
+5.57%
52-Week Range
Skr13.15 - Skr29.00
All Time High
Skr1625.78
About

Scandinavian Real Heart AB (Publ) engages in the design and development of an artificial heart. The company develops Realheart TAH to treat advanced stage heart failure. It also develops RealVAD for pulsating left ventricle assist; PulsePump, a pulsating flow for heart and lung machines; and Sternal Prosthesis to fix the sternum after open-chest surgery. The company was founded in 1999 and is bas… Read more